CONCORD BIOTECH
Back to Income Statement
|
CONCORD BIOTECH Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,017 Cr | ₹853 Cr | ₹71 Cr | ₹617 Cr | ₹5,123 Cr |
What is the latest Revenue of CONCORD BIOTECH ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹1,017 Cr |
| Mar2024 | ₹853 Cr |
| Mar2023 | ₹71 Cr |
| Mar2022 | ₹617 Cr |
| Mar2021 | ₹5,123 Cr |
How is Revenue of CONCORD BIOTECH Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,017 Cr | 19.20 | |
| Mar2024 | ₹853 Cr | 1,096.71 | |
| Mar2023 | ₹71 Cr | -88.44 | |
| Mar2022 | ₹617 Cr | -87.96 | |
| Mar2021 | ₹5,123 Cr | - | |
Compare Revenue of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹13,389.3 Cr | 1.4% | 6.7% | -28.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,989.0 Cr | 1.7% | 6.4% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,471.0 Cr | 3% | 2.8% | 0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,290.0 Cr | 2.3% | 9.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹117,820.0 Cr | 0.3% | 6.1% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,730.0 Cr | -0.1% | 8.9% | 1.9% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | 1.4% |
6.7% |
-28.5% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses